DX
Last reporting period 31 Dec, 2023
Updated 18 Sep, 2024
Last price
—
Market cap $B
0.148
Exchange
XLON - London Stock Exchange
7.1
Last period Current ratio
What is Current ratio ?
Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.
See also Diaceutics
Company Analysis
DXRX.L valuation, rating, competitors, insights and company profile
Eyestock Rating
DXRX.L financial analysis by Eyestock methodology
Valuation
DXRX.L valuation using historical relative method
Statements
DXRX.L Income Statements, Balance Sheet and Cash Flow Statements
Dividends
DXRX.L dividend yield and annual dividend
Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.
Diaceutics`s Current ratio for the last twelve months ended 2023-12-31 is 7.1
